Graham, Goodreau, and Hamilton are Awarded Grant to Study STI Control Among MSM
Posted: 2/8/2024 (CSDE Research)
CSDE Affiliates Dr. Susan Graham (Medicine and Global Health), Dr. Steven Goodreau (Anthropology), and CSDE Scientist Dr. Deven Hamilton recently received a grant from the National Institute of Allergy and Infectious Diseases (NIAID for their research, titled “WHO-recommended Periodic Presumptive Treatment versus Doxycycline Post-Exposure Prophylaxis for STI Control among Cisgender Men Who Have Sex with Men in Kenya“. Authors propose a randomized clinical trial with participants assigned to WHO-recommended periodic presumptive treatment (PPT) or doxycycline post-exposure prophylaxis (doxyPEP), compared to standard syndromic treatment. This work will provide critical data needed to inform guidelines and improve STI control among MSM in sub-Saharan Africa and other resource-limited settings, including modelled estimates of the health and economic impact of scaling up these two interventions on STI control among MSM and their partners in Kenya.
Other UW collaborators are Scott McClelland in Medicine, Monisha Sharma in Global Health, and S.O. Soge in Global Health. Graham’s co-PI is Dr. Eduard Sanders from the Aurum Institute, who is based in Kenya. Kenyan site PIs include Dr. Fredrick Otieno with Nyanza Reproductive Health Society in Kisumu and Dr. Joshua Kimani with Partners for Health & Development in Africa.